SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-047449
Filing Date
2021-09-10
Accepted
2021-09-13 06:46:09
Documents
4
Effectiveness Date
2021-09-10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea147207-s8_unicycive.htm S-8 61468
2 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea147207ex5-1_unicycive.htm EX-5.1 11395
3 CONSENT OF MAYER HOFFMAN MCCANN P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING F ea147207ex23-1_unicycive.htm EX-23.1 2368
4 GRAPHIC ex5-1_001.jpg GRAPHIC 3076
  Complete submission text file 0001213900-21-047449.txt   80605
Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259476 | Film No.: 211248559
SIC: 2834 Pharmaceutical Preparations